CURX
NASDAQ · Pharmaceuticals
Curanex Pharmaceuticals Inc
$0.20
+0.00 (+0.05%)
Open$0.19
Previous Close$0.19
Day High$0.20
Day Low$0.19
52W High$9.18
52W Low$0.18
Volume—
Avg Volume131.9K
Market Cap5.53M
P/E Ratio—
EPS$-0.26
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.70M | 1.62M | 1.35M |
| Net Income | 499.2K | 484.2K | 288.0K |
| Profit Margin | 29.3% | 29.9% | 21.3% |
| EBITDA | 775.5K | 724.0K | 543.0K |
| Free Cash Flow | 289.5K | 292.3K | 286.4K |
| Rev Growth | +22.0% | +2.7% | +4.4% |
| Debt/Equity | 0.23 | 0.19 | 0.17 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |